| Viatris Pharma GmbH - Inhixa 4000 IE (40 mg), Injektionslösung |
| 67454 | | 02 | | Inhixa 4000 IE (40 mg) | | Injektionslösung | | B01AB05 | | Enoxaparin | | 10.06.2020 | | |
|
| Composition |
| enoxaparinum natricum 40 mg corresp. 4000 U.I. anti-Xa, aqua ad iniectabile q.s. ad solutionem pro 0.4 ml corresp. natrium 0.23 mmol. |
| Packungsbestandteile |
| Solution injectable | | | | | | | | Principe actif | Concentr. |
|---|
| Enoxaparine Sodique | 40 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Enoxaparine Sodique | 40 mg |
| | | | Agents auxilliaires |
|---|
| Anti-Xa |
| |
|
|
